Trade Summary
1 week ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Spyglass Pharma, Inc. (SGP), purchased 3,690,000 shares at $16.00 per share, for a total transaction value of $59,040,000.00. Following this transaction, Ra Capital Management, L.P. now holds 2,054,678 shares of SGP.
This purchase represents a 226.00% decrease in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.
